323 related articles for article (PubMed ID: 3197645)
1. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
2. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
3. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
5. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study.
Jin SL; Han VK; Simmons JG; Towle AC; Lauder JM; Lund PK
J Comp Neurol; 1988 May; 271(4):519-32. PubMed ID: 3385016
[TBL] [Abstract][Full Text] [Related]
6. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
Larsson LI; Moody AJ
J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
[TBL] [Abstract][Full Text] [Related]
7. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C
Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
[TBL] [Abstract][Full Text] [Related]
9. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat.
Fothergill LJ; Ringuet MT; Sioras E; Hunne B; Fazio Coles TE; Martins PR; Furness JB
Cell Tissue Res; 2019 Feb; 375(2):359-369. PubMed ID: 30259122
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
11. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro.
Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL
Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861
[TBL] [Abstract][Full Text] [Related]
12. Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes.
Rodier G; Magous R; Mochizuki T; Le Nguyen D; Martinez J; Bali JP; Bataille D; Jarrousse C
Endocrinology; 1999 Jan; 140(1):22-8. PubMed ID: 9886802
[TBL] [Abstract][Full Text] [Related]
13. Role of prohormone convertases in the tissue-specific processing of proglucagon.
Dhanvantari S; Seidah NG; Brubaker PL
Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
[TBL] [Abstract][Full Text] [Related]
14. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
[TBL] [Abstract][Full Text] [Related]
15. Glicentin immunoreactive cells: their relationship to glucagon-producing cells.
Ravazzola M; Siperstein A; Moody AJ; Sundby F; Jacobsen H; Orci L
Endocrinology; 1979 Aug; 105(2):499-508. PubMed ID: 378654
[TBL] [Abstract][Full Text] [Related]
16. Activation of the hepatic glycine cleavage enzyme system by glucagon and glucagon-related peptides.
Mabrouk GM; Brosnan JT
Can J Physiol Pharmacol; 1997 Sep; 75(9):1096-100. PubMed ID: 9365819
[TBL] [Abstract][Full Text] [Related]
17. Oxyntomodulin reduces hydromineral transport through rat small intestine.
Beauclair F; Eto B; Pansu D; Rodier G; Mochizuki T; Martinez J; Bataille D; Jarrousse C
Dig Dis Sci; 1998 Aug; 43(8):1814-23. PubMed ID: 9724174
[TBL] [Abstract][Full Text] [Related]
18. Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney.
Kervran A; Dubrasquet M; Blache P; Martinez J; Bataille D
Regul Pept; 1990 Oct; 31(1):41-52. PubMed ID: 2270317
[TBL] [Abstract][Full Text] [Related]
19. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
20. Distribution and molecular forms of glucagon-like peptide in the dog.
Suda K; Takahashi H; Fukase N; Manaka H; Tominaga M; Sasaki H
Life Sci; 1989; 45(19):1793-8. PubMed ID: 2593768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
